BioPharm International, January 2011 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, January 2011
Features
High-Throughput Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies
By Daryl Fernandes
An approach to biopharmaceutical development that combines Quality by Design with a suite of visual informatics tools to reduce scale-up risks.
BioPharm International's 5th Annual Empolyment Survey
By Chitra Sethi
How did biopharmaceutical professionals fare during a year of hiring freezes, high anxiety, and increased workload? Our survey finds out.
Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors
By A. Poles Lahille , C. Richard , S. Fisch , D. Pedelaborde , S. Gerby , V. Perrier , D. Balbuena , R. Trieau , L. Valognes , D. Peyret
A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.
Regulatory Beat
Costs and Compliance Dominate Agenda for 2011
By Jill Wechsler
Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
From the Editor
Following on Follow-Ons
By Michelle Hoffman
So often a leader on the world stage, the US is a laggard when it comes to regulating follow-on biologics.
Final Word
The Case for Insourcing
By Mike Gamble
Why this workforce trend is well-suited for pharmaceutical companies.
Burrill on Biotech
Biotech Writes its New "Play Book"
By G. Steven Burrill
Business models that were used to create current value are no longer going to be effective going forward.
Outsourcing Insights
What to Watch For in 2011
By Jim Miller
CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

ADVERTISEMENT

ADVERTISEMENT

Click here